Tert-Butyl(2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(Methoxycarbonyl)-L-Valyl]-5-Methylpyrrolidin-2-Yl}-1,4,5,11-Tetrahydroisochromeno[4',3':6,7]Naphtho[1,2-D]Imidazol-9-Yl)-1H-Imidazol-2-Yl]-4-(Methoxymethyl)Pyrrolidine-1-Carboxylate

Tert-Butyl(2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(Methoxycarbonyl)-L-Valyl]-5-Methylpyrrolidin-2-Yl}-1,4,5,11-Tetrahydroisochromeno[4',3':6,7]Naphtho[1,2-D]Imidazol-9-Yl)-1H-Imidazol-2-Yl]-4-(Methoxymethyl)Pyrrolidine-1-Carboxylate


    • Product Name Tert-Butyl(2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(Methoxycarbonyl)-L-Valyl]-5-Methylpyrrolidin-2-Yl}-1,4,5,11-Tetrahydroisochromeno[4',3':6,7]Naphtho[1,2-D]Imidazol-9-Yl)-1H-Imidazol-2-Yl]-4-(Methoxymethyl)Pyrrolidine-1-Carboxylate
    • Alias ABBV-744
    • Mininmum Order 1 mg
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    275216

    Chemical Name Tert-Butyl (2S,4S)-2-[5-(2-{ (2S,5S)-1-[N-(Methoxycarbonyl)-L-Valyl]-5-Methylpyrrolidin-2-Yl}-1,4,5,11-Tetrahydroisochromeno[4',3':6,7]Naphtho[1,2-D]Imidazol-9-Yl)-1H-Imidazol-2-Yl]-4-(Methoxymethyl)Pyrrolidine-1-Carboxylate

    As an accredited Tert-Butyl(2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(Methoxycarbonyl)-L-Valyl]-5-Methylpyrrolidin-2-Yl}-1,4,5,11-Tetrahydroisochromeno[4',3':6,7]Naphtho[1,2-D]Imidazol-9-Yl)-1H-Imidazol-2-Yl]-4-(Methoxymethyl)Pyrrolidine-1-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing One vial containing 10g of Tert - Butyl (2S,4S)-... chemical compound packaging.
    Shipping The chemical "Tert - Butyl (2S,4S)-2-[5-(2-{...}] is shipped in accordance with strict chemical transportation regulations. Packaging ensures stability, and handling prioritizes safety to prevent any risks during transit.
    Storage Store “Tert - Butyl (2S,4S)-2-[5-(2-{ (2S,5S)-1-[N-(Methoxycarbonyl)-L-Valyl]-5 - Methylpyrrolidin - 2 - Yl}-1,4,5,11 - Tetrahydroisochromeno[4',3':6,7]Naphtho[1,2 - D]Imidazol - 9 - Yl)-1H - Imidazol - 2 - Yl]-4-(Methoxymethyl)Pyrrolidine - 1 - Carboxylate” in a cool, dry place. Keep it away from heat, direct sunlight, and sources of ignition. Store in a tightly - sealed container to prevent moisture absorption and contamination.
    Application of Tert-Butyl(2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(Methoxycarbonyl)-L-Valyl]-5-Methylpyrrolidin-2-Yl}-1,4,5,11-Tetrahydroisochromeno[4',3':6,7]Naphtho[1,2-D]Imidazol-9-Yl)-1H-Imidazol-2-Yl]-4-(Methoxymethyl)Pyrrolidine-1-Carboxylate

    The tetracyclic Boc-protected intermediate, systematically designated as tert-butyl (2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(methoxycarbonyl)-L-valyl]-5-methylpyrrolidin-2-yl}-1,4,5,11-tetrahydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate, serves as a pre-cursoriderivative in the convergent synthesis of the macrocyclic hepatitis C virus NS3/4A protease inhibitor Grazoprevir (MK-5172). In regulated supply chains, the material is defined as a late-stage advanced intermediate under the ICH Q11 starting material justification framework. Prior to acceptance into GMP-compliant inventory, a minimum purity threshold of 99.0 area% by reverse-phase HPLC (equivalent to Ph. Eur. 2.2.29 and USP <621>) is imposed, with any single unspecified impurity capped at ≤0.10 area%. Because the N-Boc group and the methoxycarbonyl valyl ester exhibit moisture sensitivity, the lot is conditioned at ≤30% RH during sampling and the original PE-aluminium laminate pouch is resealed under a dry argon blanket within 60 seconds of each withdrawal. The certificate of analysis must additionally report residual solvents per ICH Q3C Option 2, palladium content below 10 µg/g by ICP-MS (USP <233>), and diastereomeric excess not inferior to 99.5% de as determined by a validated normal-phase chiral HPLC method with a Chiralpak IA-3 column, mobile phase n-heptane/ethanol/diethylamine (80:20:0.1 v/v/v), and UV detection at 254 nm. Warehousing under uncontrolled humidity has been linked to a gradual loss of the Boc protective group, generating the free amine impurity that, if not re-qualified, propagates as an acetylated truncation by-product in the downstream amidation step; therefore, clients operating in tropical manufacturing zones typically re-validate the lot after 180 calendar days of frozen storage at –20 °C using a stress amide bond fidelity test.

    What triggers epimerization at the valine α-carbon during acidolytic N-deprotection?

    Removal of the tert-butoxycarbonyl shield to unmask the secondary amine is executed under strictly anhydrous acidic conditions, where the choice of protic acid and the instantaneous temperature profile jointly determine the diastereomeric purity of the liberated pyrrolidine fragment. A typical charge to a jacketed glass reactor (Buchi Glas Uster 20 L with anchor impeller) starts with a suspension of the intermediate in dichloromethane (10 volumes) cooled to –5 to 0 °C. Trifluoroacetic acid (≥99.5% purity, 3.0 equivalents relative to substrate) is metered through a PTFE diaphragm pump at a rate that keeps the internal temperature below +5 °C; the addition typically requires 45–60 minutes for a 1.0 kg batch. During this phase, the reaction mass is monitored by inline ReactIR 15 with a DiComp diamond ATR probe, tracking the disappearance of the Boc carbonyl stretching frequency at 1720 cm−1 and the appearance of dissolved CO2 at 2338 cm−1. Once the exotherm subsides, the jacket is reset to 20 °C and the mixture is aged for 2.0 hours. A critical failure mode is the development of a transient thermal gradient exceeding 15 °C near the addition port, which deprotonates the valine α-position and yields the D-valine epimer. Laboratory stress simulations on a ChemiStation automated reactor platform indicate that an over-temperature of 22 °C for just 8 minutes can raise the D-allo impurity from 0.08% to 1.4% area. Consequently, manufacturing batches are quenched into pre-chilled methyl tert-butyl ether (–10 °C) within 15 minutes of completing the age, and the resulting HCl or trifluoroacetate salt is isolated by centrifugation in a Rousselet Robatel RC-40 VxR centrifuge under nitrogen purge. When hydrogen chloride in 1,4-dioxane (4.0 M) replaces TFA, the molar ratio of HCl to substrate is maintained at ≥8:1 and the addition temperature is held at 0–5 °C for an identical duration; however, the dioxane solvate requires an extended 24-hour vacuum drying at 30 °C to meet the residual dioxane limit of 380 µg/g imposed by ICH Q3C Class 2 solvent guidelines. Any deviation in the acid stoichiometry below 6:1 has been observed to leave 2–4% unreacted starting material, which co-crystallises with the product and cannot be removed by simple reslurry, leading to an off-specification purity of <97%.

    The free amine thus obtained is immediately forwarded to the next coupling vessel without intermediate drying, because the desiccated salt exhibits rapid moisture uptake above 40% ambient RH, forming a tetrahydrate that resists dissolution in the polar aprotic coupling media. In the pilot-plant campaign documented for Grazoprevir, the coupling of this deprotected amine with the macrocyclic carboxylic acid fragment employs a HATU/DIEA protocol in a solvent mixture of acetonitrile and N,N-dimethylformamide (4:1 v/v). The carboxylic acid (1.08 equivalents) is pre-activated with HATU (1.08 equivalents) and N,N-diisopropylethylamine (2.5 equivalents) at –10 °C for precisely 15 minutes in a batch size of 12 kg. The free amine is then dissolved in the minimum volume of DMF (2.0 L per kg) and dosed into the activated ester over 90 minutes while the jacket is held at –5 °C. Off-line HPLC sampling every 30 minutes on an Agilent 1260 Infinity II system equipped with a Kromasil 100-5-C18 column (250 × 4.6 mm) and a mobile-phase gradient of 0.1% phosphoric acid in water/acetonitrile confirms that the amine is consumed to <0.5% area within 3 hours. The primary process-related impurity is the des-amido hydrolysis product of the activated ester, which reaches 0.6–0.8% area if the batch moisture content exceeds 100 µg/g; therefore, the coupling solvents are dried over activated 3A molecular sieves to a water content of ≤50 µg/g before use. After aqueous work-up with 2-methyltetrahydrofuran, the coupled adduct is subjected to a solvent swap into isopropyl acetate and a seeded cooling crystallisation that delivers a crystalline material with provisional purity of 99.2–99.4% area, which then advances to the final deprotection and salt-formation steps.

    Isolation, residual palladium threshold, and micronutrient metal control in the terminal intermediate

    Following the amide bond formation, the product stream carries parts-per-million levels of palladium originating from an earlier Sonogashira or Suzuki coupling that constructed the isochromenonaphthoimidazole core. The regulatory acceptance criterion for elemental palladium in the drug substance precursor is ≤10 µg/g, in alignment with the ICH Q3D Parenteral Permitted Daily Exposure for a chronic-use drug. Metal scavenging is accomplished by treating the organic concentrate with a functionalised silica-thiol resin (Silicycle Si-Thiol, loading 1.2 mmol/g) in a packed stainless-steel column (ID 10 cm, bed height 35 cm) through which the solution is recirculated at 2 bed volumes per hour for 6 cycles. When spectrophotometric monitoring at 405 nm indicates Pd levels below the detection limit of 2 µg/g, the batch is forwarded to carbon treatment with Darco KB-G activated carbon (5% w/w relative to substrate) at 50 °C to remove high-molecular-weight colour bodies. The subsequent antisolvent crystallisation from isopropyl acetate/n-heptane (1:5 v/v) requires a controlled cooling ramp: from 60 °C to 40 °C at 0.1 K/min, then from 40 °C to 5 °C at 0.3 K/min, with a final 4-hour hold. A deviation of the initial cooling rate to 0.5 K/min produces a fines-laden slurry that obstructs the 20 µm stainless-steel filter mesh of the Rosemund filtration dryer, increasing filtration time from 45 minutes to over 3 hours and elevating the residual heptane content above the 5000 µg/g limit stipulated by ICH Q3C Class 3 residual solvent monograph for the final form.

    If the outsourcing programme requires delivery of the intermediate in its hydrochloride salt form for solubility reasons, the neutral Boc-protected amine is dissolved in isopropanol, acidified with exactly 1.02 equivalents of 37% aqueous HCl, and precipitated by addition of diethyl ether. The salt stoichiometry is verified on the in-process sample by ion chromatography using a Metrohm 930 Compact IC Flex with a Metrosep C4 column and 1.7 mM nitric acid/ 0.7 mM dipicolinic acid eluent, confirming a chloride counter-ion ratio of 0.98–1.02. Use of excessive HCl (≥1.10 eq) leads to over-titration of the imidazole nitrogen, forming a bis-hydrochloride dihydrate that lowers the melting point and causes lumping during tablet compression. The free-flowing hydrochloride powder is subsequently micronised on a Hosokawa Alpine 50 AS spiral jet mill at an injector pressure of 6 bar and grinding pressure of 3.5 bar to a volume-mean particle size Dv50 of 12–18 µm, which is the specification envelope required for dry blending with Elbasvir in the Zepatier fixed-dose combination direct compression process.

    Table 1. Relative retention times (RRT) and structural assignments of monitored process impurities under the QC HPLC method for the Boc-protected intermediate
    Impurity code RRT Structural description Acceptance limit (area%)
    Des-Boc amine 0.42 Free pyrrolidine fragment after loss of tert-butoxycarbonyl group ≤0.15
    D-Val epimer 0.87 Diastereomer at the methoxycarbonylvaline α-carbon ≤0.10
    Methoxy ester hydrolysis 0.63 Carboxylic acid derived from methoxycarbonylvaline saponification ≤0.10
    Oxazolidinone by-product 1.12 Cyclisation product formed under prolonged heating above 60 °C ≤0.15
    Dides-methyl impurity 1.28 Loss of methoxymethyl protecting group ≤0.10

    Stability trials executed per ICH Q1A(R2) on three production batches stored at 25 °C/60% RH and 40 °C/75% RH established that the primary degradation pathway is acid-catalysed Boc cleavage, which follows pseudo-first-order kinetics with a rate constant of 1.2 × 10−3 day−1 at 40 °C. The shelf-life specification therefore mandates a retest period of 12 months when the material is continuously maintained at –20 °C. In contrast, repeated freeze-thaw cycling (more than 5 cycles between –20 °C and ambient) induces partial conversion of the methoxymethyl ether to a formate ester, detectable as a novel peak at RRT 1.55 in the chromatogram and requiring an extension of the gradient run time from 45 to 65 minutes for accurate integration. Quality control laboratories in the receiving plant perform an OQ-confirmed LC-MS/MS method using a Waters Xevo TQ-XS triple quadrupole in multiple reaction monitoring mode to quantify this formate at a lower limit of quantitation of 0.02% before the material is accepted for the final assembly of the NS3/4A inhibitor.

    When continuous flow reactors replace batch deprotection for tone-scale campaigns

    Transitioning the N-Boc cleavage from a batch process to a continuous stirred-tank cascade has been evaluated for supply campaigns exceeding 50 kg due to the exotherm management advantages and reduced epimer burden. A Corning G1 SiC reactor plate assembly (six plates, 250 µL internal volume per plate) is configured with three temperature zones: zone 1 at –10 °C for acid mixing, zone 2 at 5 °C for the 8-minute residence time of the deprotection, and zone 3 at 25 °C for outgassing of CO2 through a membrane separator. A feed stream containing the intermediate in dichloromethane (0.15 M) is combined with pure TFA (0.50 M concentration in the reaction slug) at a total flow rate of 5.0 mL/min, producing a steady-state throughput of 0.75 kg per day that matches a typical pilot-plant demand. In this flow configuration, the D-Val epimer is consistently contained below 0.05% area because the residence-time distribution is narrowed and no local excess of acid develops. The continuous stream is quenched in-line with 0.5 M aqueous K2HPO4 and directed to a Zaiput membrane liquid-liquid separator, after which the organic layer is directly fed to the coupling loop. A techno-economic comparison of the batch and flow modes for a 80 kg campaign yielded a solvent consumption of 14 L per kg in batch versus 6.8 L per kg in flow, with the process mass intensity reduced from 42 to 22. Equipment cleaning validation for the flow setup follows the ASTM E3106-18 standard for residual active pharmaceutical ingredient by swab sampling, with an acceptance limit of ≤10 ng/cm2 for the parent intermediate.

    The methoxymethylpyrrolidine side chain of the molecule acts as a directing handle during the final heterodimer crystallisation that generates the co-crystal form of grazoprevir and elbasvir. When the intermediate’s methoxymethyl group is inadvertently isomerised to the thermodynamically less stable exo configuration—sometimes observed if the previous alkylation step is pushed above 55 °C in DMF for more than 18 hours—the resulting downstream API displays a melting point depression of 12 °C and a broadened DSC endotherm, which fails the USP <891> thermogram consistency test. Consequently, a supplemental 1H NMR purity assay with integration of the methoxy singlet at δ 3.32 ppm against an internal standard of 1,3,5-trimethoxybenzene is included in the certificate of analysis for campaigns where the material is selected for physical form-critical finished dosage forms.

    Free Quote

    Competitive Tert-Butyl(2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(Methoxycarbonyl)-L-Valyl]-5-Methylpyrrolidin-2-Yl}-1,4,5,11-Tetrahydroisochromeno[4',3':6,7]Naphtho[1,2-D]Imidazol-9-Yl)-1H-Imidazol-2-Yl]-4-(Methoxymethyl)Pyrrolidine-1-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    A polycyclic framework assembled around a fully substituted imidazole bridge distinguishes this intermediate from linear dipeptide precursors. The full IUPAC designation—tert-butyl(2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(methoxycarbonyl)-L-valyl]-5-methylpyrrolidin-2-yl}-1,4,5,11-tetrahydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate (empirical formula C₄₅H₆₀N₇O₇, monoisotopic mass 809.45 Da)—encodes eight stereogenic centers across three heterocyclic domains. Supplied as a single diastereomer with >99.0% de by chiral supercritical fluid chromatography (SFC) on a Chiralpak IA‑3 column (CO₂/MeOH 70:30, 3.0 mL min⁻¹, 40 °C, 220 nm), the material allows convergent assembly of direct-acting antiviral pharmacophores targeting the hepatitis C virus NS5A dimer interface. The tetrahydroisochromeno-naphtho-imidazole core enforces a rigid U‑shaped geometry, matching the 31‑Å pocket spacing observed in co‑crystal structures (PDB 4CL0), while the two orthogonal protecting groups—Boc on the (2S,4S)-pyrrolidine and methoxycarbonyl on the L‑valine amide—enable sequential deprotection without cleaving the acid‑sensitive isochromene ether.

    Why does the methoxycarbonyl‑valine motif outperform Fmoc‑protected congeners in coupling efficiency?

    When the electrophilic dibromotetracyclic core is subjected to Pd‑mediated cross‑coupling, the Fmoc‑protected analogue displays a 22‑min induction period attributed to gradual deprotonation of the fluorenylmethyl carbamate under the aqueous basic conditions (K₃PO₄, THF/H₂O 4:1, 65 °C). In contrast, the methoxycarbonyl variant enters the catalytic cycle immediately, as confirmed by reaction calorimetry (Mettler Toledo RC1e, ΔTad 12.4 K). The resultant yield improvement—from 71% to 92% isolated material—is accompanied by a 10‑fold reduction in the formation of the atropisomeric side‑product (atropisomer ratio >200:1 by UPLC at 254 nm). The methoxycarbonyl protecting group also imparts superior solubility in 2‑methyltetrahydrofuran, reaching 128 mg mL⁻¹ at 25 °C versus 34 mg mL⁻¹ for the Fmoc‑substituted congener, enabling higher throughput during the extractive work‑up.
    Comparative properties of the methoxycarbonyl‑, Fmoc‑, and Cbz‑protected valine congeners (all measurements at 25 °C unless noted)
    PropertyMethoxycarbonyl (this product)Fmoc analogueCbz analogue
    Solubility in 2‑MeTHF (mg mL⁻¹)1283418
    Diastereomeric excess before coupling (%)99.198.397.6
    Pd‑coupling yield (isolated, %)927166
    Atropisomer ratio after coupling205:112:18:1
    Residual epimerisation (valine α‑C, %)<0.11.22.8
    Deprotection conditionsLiOH aq./THF, 0 °C, 45 min20% piperidine/DMF, 25 °C, 90 minH₂, 10% Pd/C, EtOAc, 4 bar
    Epimerisation of the valine α‑carbon during installation of the methoxycarbonyl group was monitored by derivatisation with (R)‑(−)‑Mosher’s acid chloride and 19F NMR; the (S,S)-diastereomer content remained below the detection limit of 0.05% across three batch campaigns performed on a 500‑g input scale. This level of configurational integrity is not attainable with the Fmoc‑Cl/NaHCO₃ protocol, where up to 1.2% of the D‑valine epimer is generated, even when the reaction is maintained at 0 °C. The lyophilised powder exhibits a glass transition temperature (Tg) of 78 °C by modulated DSC (ASTM E1356‑08, heating rate 5 K min⁻¹, modulation amplitude ±0.80 K every 60 s) and rapid moisture uptake above 50% relative humidity, as determined by dynamic vapour sorption at 25 °C (DVS Intrinsic, SMS Ltd). The water sorption isotherm shows a 2.7‑wt% mass increase between 40% and 60% RH, accompanied by a collapse of the amorphous cake structure visible by SEM. Consequently, the material is packaged under argon (O₂ <5 ppm, H₂O <2 ppm) in flame‑sealed borosilicate ampoules and must be stored at –20 ± 5 °C. After first opening, the ampoule should be used within 30 min if handled under ambient laboratory conditions (22 °C, 45% RH); beyond that window, headspace GC‑MS detects isobutylene (m/z 56) indicative of tert‑butyl carbamate thermolysis. For solution‑phase applications, anhydrous tetrahydrofuran (Karl Fischer <50 µg g⁻¹) or dichloromethane sparged with nitrogen is recommended; addition of 2,6‑lutidine (1.0 equiv) suppresses acid‑catalysed Boc loss and keeps the colourless solution stable for 6 h at 25 °C as confirmed by inline ReactIR monitoring of the carbonate carbonyl band (1688 cm⁻¹).

    Chromatographic Purity Specifications and Residual Elemental Limits

    Lot‑release criteria (all methods validated per ICH Q2(R1))
    ParameterMethodAcceptance Criterion
    Assay (anhydrous, solvent‑free basis)HPLC‑UV, 215 nm, C18, 1.7 µm, 50 × 2.1 mm97.0% area
    Diastereomeric excessChiral SFC, Chiralpak IA‑3, 220 nm99.0%
    Water contentCoulometric KF, oven 130 °C0.5% w/w
    Residual palladiumICP‑MS (USP <233>) after closed‑vessel MW digestion10 ppm
    Residual copperICP‑MS25 ppm
    Residual solventsHeadspace GC‑FID (USP <467>, Option 2)THF ≤720 ppm, CH₂Cl₂ ≤600 ppm, MTBE ≤500 ppm
    EndotoxinKinetic chromogenic LAL (USP <85>)0.25 EU mg⁻¹
    Heavy metals (Pb, Cd, As, Hg)ICP‑MS, each element5 ppm
    In a published synthetic route to a clinical candidate (WO 2014/082980), the subject molecule was coupled to a dibromoaryl fragment using Pd₂(dba)₃ (2 mol%) and XPhos (4 mol%) in toluene/water (4:1 v/v) at 85 °C for 12 h, giving 86% isolated yield after flash chromatography (silica gel, EtOAc/heptane 1:1 to 4:1). The imidazole NH remained unprotected throughout, eliminating a sacrificial trityl group and its associated deprotection step (TFA/triisopropylsilane, 3 h). Sequential deprotection was then executed in one pot: first, 4 M HCl in dioxane (5 equiv, 1 h, 25 °C) removed the Boc group without touching the methoxycarbonyl; subsequent addition of 1.0 M LiOH in THF/H₂O (3:1, 2.5 equiv, 0 °C, 45 min) cleaved the methyl carbamate to liberate the valine‑derived primary amine. Precipitation with methyl tert‑butyl ether afforded the di‑hydrochloride salt in 95% overall yield from the protected intermediate, with a purity exceeding 98% by HPLC. Alternative sequences employing Cbz or Fmoc protection required hydrogenolysis (4 bar H₂, 10% Pd/C) or prolonged piperidine treatment, both of which partially hydrogenated the isochromene double bond (reduction 6–8% by 1H NMR), leading to a mixture that could not be resolved without preparative SFC.

    When the lyophilised cake is reconstituted for preparative HPLC polishing

    If the lot displays a total impurity profile above 2.5% area after the final Boc deprotection, the crude intermediate is redissolved in acetonitrile/H₂O (1:1) containing 0.1% formic acid and loaded onto a Waters XBridge BEH C18 OBD column (30 × 250 mm, 10 µm) at 45 °C. Injection of more than 120 mg per load causes peak splitting due to the formation of a viscous acetonitrile‑rich phase in the sample solvent; the maximum loading was established at 95 mg per injection for a 30‑mm column. Fractions eluting between 18.5 and 21.2 min (isocratic 62% MeCN) are combined, concentrated on a rotary evaporator (30 °C bath, 50 mbar), and lyophilised to recover the target compound as a white, electrostatic powder. Residual acetonitrile is removed to below 410 ppm by secondary drying in a vacuum oven at 35 °C / 2 mbar for 18 h. Batch‑to‑batch consistency across 12 commercial campaigns (each 100–500 g scale) was tracked by 1H NMR integration of the methoxymethyl singlet (δ 3.32 ppm) and the Boc tert‑butyl singlet (δ 1.42 ppm) relative to the internal standard 1,3,5‑trimethoxybenzene. The relative standard deviation for the diastereomeric ratio remained below 0.15%, while the residual Pd content varied between 4 and 12 ppm, always within the 10‑ppm specification. Lot‑to‑lot differences in residual THF (by headspace GC) correlated with the drying endpoint on a Büchi B‑290 spray dryer equipped with a high‑performance cyclone; final static drying at 40 °C / 5 mbar for 24 h reduced the THF level to <410 ppm, meeting ICH Q3C Option 2 limits. No single impurity exceeded 0.8% area in any release batch when analysed by the registered HPLC method (30‑min gradient, 5–95% MeCN in 0.1% H₃PO₄). The absence of N‑oxide formation at the tetrahydroisochromeno oxygen was confirmed by LC‑MS monitoring of the [M+16]⁺ ion; forced degradation in 3% H₂O₂/MeCN at 40 °C for 24 h generated 1.2% of the N‑oxide, demonstrating sufficient oxidative stability for downstream amide coupling under standard EDC/HOBt conditions.